Wetenschappelijke artikelen

Klik op de link voor een pdf van het artikel.

Van de Laar M, Leufkens TRM, et al. (2017) Phenotypes of sleeplessness: stressing the need for psychodiagnostics in the assessment of insomnia, Psychology, Health & Medicine, 902-910.

Perrier J, Leufkens TRM, et al. (2015). Electroencephalography during on-the-road driving in older untreated insomnia patients and normal sleepers, Biological Psychology, 20-28.

Long X, Haakma R, Leufkens TRM, et al. (2015). Effects of between- and within-subject variability on autonomic cardiorespiratory activity during sleep and their limitations on sleep staging: a multilevel analysis, Computational Intelligence and Neuroscience, doi: 10.1155/2015/583620.

Leufkens TRM, Vermeeren A. (2014). Zopiclone’s residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies, Clinical Therapeutics, 141-150.

Leufkens TRM, et al. (2014). Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study, Psychopharmacology, 2785–2798.

Leufkens TRM, et al. (2014). On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics, Psychopharmacology, 2851–2865.

Vermeeren A, Vuurman EFPM, Leufkens TRM, et al. (2014). Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use, Sleep, 489–496.

Leufkens TRM, Vermeeren A. (2009). Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo, Journal of Clinical Psychopharmacology, 432-438.

Leufkens TRM, Lund JS, Vermeeren A. (2009). Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem, Journal of Sleep Research, 387-396.

Leufkens TRM, et al. (2007). Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg, Psychopharmacology, 951-959.